ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RXRX Recursion Pharmaceuticals Inc

9.96
-0.21 (-2.06%)
After Hours
Last Updated: 16:17:26
Delayed by 15 minutes

Recursion Pharmaceuticals Financial Summary

The current RXRX market cap is 2.34B. The company's latest EPS is USD -1.3981 and P/E is -7.12.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 13.16M13.68M12.13M11.02M10.53M
Operating Income -62.57M-60.98M-69.87M-81.72M-99.55M
Net Income -60.45M-57.49M-65.33M-76.73M-93.02M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.32M3.96M10.18M39.84M44.58M
Operating Income -62.44M-84.38M-182.78M-245.73M-350.06M
Net Income -61.88M-87.01M-186.48M-239.48M-328.07M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 611.53M701.29M627.37M666.7M630.83M
Total Liabilities 223.5M215.48M197.19M197.74M192.86M
Total Equity 388.03M485.81M430.18M468.96M437.97M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 101.43M298.59M610.35M701.29M653.7M
Total Liabilities 24.59M56.56M67.41M215.48M190.26M
Total Equity -124.27M-206.29M542.94M485.81M463.44M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -38.78M-83.52M-73.32M-140.78M-213.7M
Investing 201.23M193.25M-5.34M-7.39M-7.74M
Financing 7.09M154.35M1.92M5.71M59.47M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -57.04M-45.4M-158.61M-83.52M-287.78M
Investing -3.91M-8.74M-271.74M193.25M-10.23M
Financing 120.41M246.14M458.54M154.35M140.13M
Market Cap 2.34B
Price to Earnings Ratio -7.12
Price to Sales Ratio 52.37
Price to Cash Ratio 5.96
Price to Book Ratio 5.04
Dividend Yield -

Share Statistics

Shares Outstanding 234.65M
Average Volume (1 week) 4.92M
Average Volume (1 Month) 6.68M
52 Week Change 48.66%
52 Week High 16.745
52 Week Low 4.54
Spread (Intraday) 0.01 (0.1%)

Company Info

Company Name Recursion Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.recursion.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock